News 2023
21.03.23:
Wenger Plattner advises Bachem on strategic framework agreement
On 3 March 2023, Bachem (SIX: BANB) announced the signing of a new framework agreement with an undisclosed customer to provide large volumes of peptides following a joint development project. The agreement covers a committed volume at an equivalent value of over CHF 500 million for the five-year period of 2027-2031, with significant upside potential.
Wenger Plattner (Dr. Tobias Meili) advised Bachem on the terms of the framework agreement and regarding aspects of SIX Listing Rules.